 Jennifer Armstrong
Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 12 | 2019 | 1270 | 0.930 |
Why?
| | Infant, Newborn, Diseases | 4 | 2019 | 115 | 0.910 |
Why?
| | Brain Ischemia | 6 | 2018 | 359 | 0.440 |
Why?
| | Chorioamnionitis | 1 | 2014 | 50 | 0.410 |
Why?
| | Interleukin-8 | 1 | 2014 | 269 | 0.390 |
Why?
| | Cerebral Arterial Diseases | 4 | 2016 | 50 | 0.390 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2015 | 288 | 0.380 |
Why?
| | Interleukin-1beta | 1 | 2014 | 389 | 0.360 |
Why?
| | Fetal Blood | 1 | 2014 | 327 | 0.360 |
Why?
| | Nervous System Diseases | 1 | 2014 | 286 | 0.340 |
Why?
| | Rare Diseases | 1 | 2011 | 116 | 0.320 |
Why?
| | Interleukin-6 | 1 | 2014 | 776 | 0.310 |
Why?
| | Asphyxia Neonatorum | 1 | 2010 | 21 | 0.310 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1217 | 0.300 |
Why?
| | Subarachnoid Hemorrhage | 2 | 2009 | 71 | 0.300 |
Why?
| | Cerebral Infarction | 1 | 2009 | 47 | 0.290 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2009 | 48 | 0.290 |
Why?
| | Cerebral Hemorrhage | 1 | 2009 | 125 | 0.270 |
Why?
| | Placenta | 1 | 2014 | 786 | 0.260 |
Why?
| | Infant, Premature, Diseases | 1 | 2009 | 113 | 0.260 |
Why?
| | Magnetic Resonance Imaging | 3 | 2019 | 3904 | 0.260 |
Why?
| | Infant, Newborn | 10 | 2019 | 6447 | 0.260 |
Why?
| | Developmental Disabilities | 1 | 2010 | 281 | 0.250 |
Why?
| | Cognition Disorders | 1 | 2010 | 541 | 0.230 |
Why?
| | Anemia, Sickle Cell | 1 | 2009 | 318 | 0.210 |
Why?
| | Brain Injuries | 1 | 2010 | 507 | 0.210 |
Why?
| | Brain | 3 | 2015 | 2947 | 0.210 |
Why?
| | Cohort Studies | 6 | 2014 | 6013 | 0.180 |
Why?
| | Temporal Lobe | 1 | 2019 | 105 | 0.150 |
Why?
| | Intracranial Hemorrhages | 1 | 2019 | 106 | 0.140 |
Why?
| | Prospective Studies | 6 | 2018 | 8057 | 0.120 |
Why?
| | Research Design | 2 | 2012 | 1137 | 0.110 |
Why?
| | Fibrin Fibrinogen Degradation Products | 2 | 2012 | 92 | 0.110 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2014 | 63 | 0.100 |
Why?
| | Hyperhomocysteinemia | 1 | 2013 | 26 | 0.100 |
Why?
| | Epilepsy | 1 | 2018 | 390 | 0.100 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2013 | 36 | 0.100 |
Why?
| | Apoprotein(a) | 1 | 2013 | 8 | 0.100 |
Why?
| | Child | 12 | 2018 | 22707 | 0.100 |
Why?
| | Cerebrovascular Disorders | 1 | 2014 | 104 | 0.090 |
Why?
| | Reproducibility of Results | 3 | 2016 | 3413 | 0.090 |
Why?
| | Male | 15 | 2019 | 72842 | 0.090 |
Why?
| | Migraine with Aura | 1 | 2012 | 6 | 0.090 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 848 | 0.090 |
Why?
| | Pediatrics | 2 | 2012 | 1121 | 0.090 |
Why?
| | Lipoprotein(a) | 1 | 2013 | 69 | 0.090 |
Why?
| | Thromboembolism | 1 | 2013 | 129 | 0.090 |
Why?
| | Humans | 22 | 2019 | 145474 | 0.090 |
Why?
| | Female | 14 | 2019 | 78844 | 0.080 |
Why?
| | Edema | 1 | 2012 | 125 | 0.080 |
Why?
| | Gestational Age | 1 | 2014 | 987 | 0.080 |
Why?
| | Inflammation | 2 | 2014 | 2878 | 0.080 |
Why?
| | Blood Coagulation Disorders | 1 | 2012 | 198 | 0.080 |
Why?
| | Sensitivity and Specificity | 1 | 2015 | 1997 | 0.080 |
Why?
| | Herpesvirus 3, Human | 1 | 2014 | 343 | 0.080 |
Why?
| | Herpes Zoster | 1 | 2014 | 319 | 0.080 |
Why?
| | Pia Mater | 1 | 2009 | 4 | 0.080 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 297 | 0.080 |
Why?
| | Moyamoya Disease | 1 | 2009 | 20 | 0.080 |
Why?
| | Dwarfism | 1 | 2009 | 14 | 0.080 |
Why?
| | Child, Preschool | 7 | 2018 | 11853 | 0.070 |
Why?
| | Intracranial Arteriovenous Malformations | 1 | 2009 | 53 | 0.070 |
Why?
| | Thrombophilia | 1 | 2009 | 89 | 0.070 |
Why?
| | Health Maintenance Organizations | 1 | 2009 | 105 | 0.070 |
Why?
| | Transfusion Reaction | 1 | 2009 | 61 | 0.070 |
Why?
| | Microcephaly | 1 | 2009 | 104 | 0.070 |
Why?
| | Thrombosis | 1 | 2012 | 400 | 0.070 |
Why?
| | Risk Factors | 6 | 2018 | 10885 | 0.070 |
Why?
| | Intracranial Aneurysm | 1 | 2009 | 106 | 0.070 |
Why?
| | Neurosurgical Procedures | 1 | 2009 | 202 | 0.070 |
Why?
| | Fetal Diseases | 1 | 2009 | 194 | 0.070 |
Why?
| | California | 1 | 2009 | 471 | 0.060 |
Why?
| | Neurology | 1 | 2008 | 116 | 0.060 |
Why?
| | Regression Analysis | 1 | 2009 | 1001 | 0.060 |
Why?
| | Cytokines | 1 | 2014 | 2067 | 0.060 |
Why?
| | Young Adult | 4 | 2018 | 14218 | 0.060 |
Why?
| | Proportional Hazards Models | 1 | 2009 | 1327 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2013 | 3623 | 0.060 |
Why?
| | Neuropsychological Tests | 1 | 2010 | 1134 | 0.050 |
Why?
| | Severity of Illness Index | 2 | 2010 | 2930 | 0.050 |
Why?
| | Pregnancy | 2 | 2014 | 7202 | 0.050 |
Why?
| | Infant | 6 | 2018 | 10077 | 0.050 |
Why?
| | Adolescent | 6 | 2018 | 22529 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 2121 | 0.050 |
Why?
| | Circumcision, Male | 1 | 2002 | 16 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2016 | 5904 | 0.050 |
Why?
| | Biomarkers | 2 | 2012 | 4295 | 0.040 |
Why?
| | Cerebral Angiography | 2 | 2009 | 119 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2019 | 17291 | 0.040 |
Why?
| | Colorado | 3 | 2013 | 4553 | 0.030 |
Why?
| | Adult | 3 | 2014 | 40777 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2018 | 5423 | 0.030 |
Why?
| | Incidence | 2 | 2013 | 2923 | 0.030 |
Why?
| | Neuroimaging | 1 | 2016 | 297 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2014 | 407 | 0.020 |
Why?
| | Treatment Outcome | 3 | 2013 | 11772 | 0.020 |
Why?
| | Quality Control | 1 | 2012 | 161 | 0.020 |
Why?
| | Prognosis | 2 | 2012 | 4316 | 0.020 |
Why?
| | Mutation | 2 | 2014 | 4075 | 0.020 |
Why?
| | Fibrinolysis | 1 | 2013 | 164 | 0.020 |
Why?
| | Multicenter Studies as Topic | 1 | 2012 | 412 | 0.020 |
Why?
| | Observer Variation | 1 | 2011 | 357 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2013 | 614 | 0.020 |
Why?
| | Risk | 1 | 2013 | 919 | 0.020 |
Why?
| | Delphi Technique | 1 | 2011 | 332 | 0.020 |
Why?
| | Consensus | 1 | 2011 | 477 | 0.020 |
Why?
| | Recurrence | 1 | 2012 | 1138 | 0.020 |
Why?
| | Pregnancy Trimester, Third | 1 | 2009 | 119 | 0.020 |
Why?
| | Factor VIII | 1 | 2009 | 106 | 0.020 |
Why?
| | Anastomosis, Surgical | 1 | 2009 | 162 | 0.020 |
Why?
| | Genotype | 1 | 2013 | 1852 | 0.020 |
Why?
| | Age of Onset | 1 | 2009 | 555 | 0.020 |
Why?
| | Abnormalities, Multiple | 1 | 2009 | 199 | 0.020 |
Why?
| | Cerebral Arteries | 1 | 2008 | 59 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2012 | 1508 | 0.020 |
Why?
| | Magnetic Resonance Angiography | 1 | 2009 | 251 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2009 | 422 | 0.020 |
Why?
| | Ultrasonography, Prenatal | 1 | 2009 | 295 | 0.020 |
Why?
| | Animals | 1 | 2010 | 38030 | 0.020 |
Why?
| | Thrombolytic Therapy | 1 | 2008 | 164 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2012 | 1747 | 0.010 |
Why?
| | Prevalence | 1 | 2013 | 2865 | 0.010 |
Why?
| | Physical Therapy Modalities | 1 | 2008 | 336 | 0.010 |
Why?
| | Algorithms | 1 | 2011 | 1845 | 0.010 |
Why?
| | Registries | 1 | 2011 | 2406 | 0.010 |
Why?
| | Age Factors | 1 | 2008 | 3342 | 0.010 |
Why?
| | Practice Guidelines as Topic | 1 | 2008 | 1581 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2009 | 2769 | 0.010 |
Why?
| | Time Factors | 1 | 2009 | 7123 | 0.010 |
Why?
| | United States | 1 | 2013 | 16098 | 0.010 |
Why?
|
|
Armstrong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|